(Q35554487)

8 August 2017

1 reference

title

Diagnosis and treatment of antibody-mediated kidney allograft rejection (English)

1 reference

8 August 2017

Georg Böhmig

1

1 reference

8 August 2017

Heinz Regele

series ordinal

2

1 reference

8 August 2017

language of work or name

1 reference

8 October 2003

1 reference

full work available at URL

8 August 2017

http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1007%2Fs00147-003-0658-3

1 reference

10.1007/S00147-003-0658-3

DOI

https://api.crossref.org/works/10.1007/S00147-003-0658-3

http://onlinelibrary.wiley.com/wol1/doi/10.1007/s00147-003-0658-3/fullpdf

19 March 2024

1 reference

10.1007/S00147-003-0658-3

DOI

https://api.crossref.org/works/10.1007/S00147-003-0658-3

19 March 2024

published in

Transplant International

1 reference

8 August 2017

volume

16

1 reference

8 August 2017

issue

11

1 reference

8 August 2017

page(s)

773-787

1 reference

Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

Acute humoral renal allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

Anti-HLA antibodies after solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

Early renal graft dysfunction. The role of preformed antibodies to DR-typed lymphoblastoid cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

Tortuosity of the white matter medullary arterioles is related to the severity of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

The role of complement in inflammation and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

Complement activation in early protocol kidney graft biopsies after living-donor transplantation1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

When renal allografts turn DARC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

Peritubular capillary basement membrane reduplication in allografts and native kidney disease: a clinicopathologic study of 278 consecutive renal specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

Impact of donor-specific antibodies on chronic rejection occurrence and graft loss in renal transplantation: posttransplant analysis using flow cytometric techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

Tissue injury and repair in allografts: novel perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

Complement-mediated regulation of tissue factor activity in endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

A complement-dependent model of thrombotic thrombocytopenic purpura induced by antibodies reactive with endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

Immunopathogenesis of accelerated allograft rejection in sensitized recipients: humoral and nonhumoral mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

Peri-operative immunoadsorption in sensitized renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

Immunoadsorption of sensitized kidney transplant candidates immediately prior to surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

A case of acute antidonor antibody-mediated humoral rejection after renal transplantation with specific consideration of serial graft biopsy histology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

Transplant accommodation in highly sensitized patients: a potential role for Bcl-xL and alloantibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

Reversal of steroid- and anti-lymphocyte antibody-resistant rejection using intravenous immunoglobulin (IVIG) in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

A randomized and prospective study comparing treatment with high-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

Successful renal transplant outcome after intravenous gamma-globulin treatment of a highly sensitized pediatric recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

Acute renal failure in a renal allograft recipient treated with intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

B-lymphocyte depletion therapy in rheumatoid arthritis and other autoimmune disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

Successful management of an ABO-mismatched lung allograft using antigen-specific immunoadsorption, complement inhibition, and immunomodulatory therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

Effects of specific anti-B and/or anti-plasma cell immunotherapy on antibody production in baboons: depletion of CD20- and CD22-positive B cells does not result in significantly decreased production of anti-alphaGal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

Local synthesis of complement component C3 regulates acute renal transplant rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

IDENTIFICATION OF PATIENTS AT HIGH RISK OF GRAFT LOSS BY PRE- AND POSTTRANSPLANT MONITORING OF ANTI-HLA CLASS I IgG ANTIBODIES BY ENZYME-LINKED IMMUNOSORBENT ASSAY

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2003.TB00241.X

10.1111/J.1432-2277.2003.TB00241.X

21 January 2018

Identifiers

DOI

1 reference

10.1007/S00147-003-0658-3

8 August 2017

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14534774

19 March 2024

1 reference